Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012
Sylvia K. Plevritis(Stanford University), Jeanne S. Mandelblatt(Georgetown University), Young Chandler(Georgetown University Medical Center), Cong Xu(Stanford University), Ronald E. Gangnon(University of Wisconsin–Madison), Oğuzhan Alagöz(University of Wisconsin–Madison), Juhee Song(The University of Texas MD Anderson Cancer Center), Sandra J. Lee(Dana-Farber Cancer Institute), Diego A. Muñoz(Stanford University), Xuelin Huang(The University of Texas MD Anderson Cancer Center), Aimee M. Near(IQVIA (United Kingdom)), Clyde B. Schechter(Albert Einstein College of Medicine), Allison W. Kurian(Stanford University), Donald A. Berry(Berry & Associates (United States)), Harry J. de Koning(Erasmus MC), Nicolien T. van Ravesteyn(Erasmus MC), Jeroen J. van den Broek(Erasmus MC), Yisheng Li(The University of Texas MD Anderson Cancer Center), Mehmet Ali Ergün(University of Wisconsin–Madison), Hui Huang(Harvard University), Amy Trentham‐Dietz(University of Wisconsin–Madison), Natasha K. Stout(Harvard Pilgrim Health Care), Brian L. Sprague(University of Vermont)
Cited by 301
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862